Intel-backed Enterprise 2.0 suite is discontinued

09.01.2009

SpikeSource has notified the about 80 companies that use SuiteTwo regarding the phaseout and will provide migration assistance to them, Sartorio said. "We're going to be there to help customers, advise them, to do what's right for their deployments and users," he said.

One customer that will seek migration assistance from SpikeSource is Clinical Trial Semantics Inc. CTSi uses SuiteTwo as a key part of its project to build a Web-based system to help cancer patients discuss with their doctors appropriate clinical trials they can consider participating in as part of their treatment.

"We probably over-invested in a platform that clearly didn't have the user base," said CTSi CEO Etienne Taylor.

So far, SpikeSource has been a very responsive vendor to CTSi during the year or so that the nonprofit has been using SuiteTwo.

"Their professional services department has helped us way above and beyond the economics of having us as a customer," Taylor said. "They've been wonderful."